Australia markets closed

Sartorius Stedim Biotech S.A. (0RG8.IL)

IOB - IOB Delayed price. Currency in EUR
Add to watchlist
178.40-3.85 (-2.11%)
As of 01:06PM BST. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
116,600
107,100
223,600
59,762
-
Other short-term investments
-
25,900
13,700
10,856
8,377
Total cash
116,600
107,100
237,300
70,618
-
Net receivables
293,800
404,600
338,900
242,918
-
Inventory
882,400
1,024,800
783,000
471,034
-
Other current assets
66,000
89,300
63,300
59,218
-
Total current assets
1,415,100
1,671,200
1,455,600
873,945
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
2,175,700
1,733,059
1,296,400
943,450
-
Accumulated depreciation
-542,400
-440,962
-368,000
-299,178
-
Net property, plant and equipment
1,633,300
1,292,097
928,400
644,272
-
Goodwill
2,851,900
1,136,400
820,700
725,148
-
Intangible assets
1,736,200
876,900
684,500
571,881
-
Other long-term assets
2,700
2,303
700
510
-
Total non-current assets
6,324,800
3,394,200
2,495,500
1,982,789
-
Total assets
7,739,900
5,065,400
3,951,100
2,856,733
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
57,700
4,400
25,500
13,112
-
Accounts payable
257,100
250,200
251,300
174,733
-
Other current liabilities
103,100
97,200
85,300
55,471
-
Total current liabilities
937,300
1,035,900
1,037,100
567,840
-
Non-current liabilities
Long-term debt
3,509,800
1,020,700
521,100
515,657
-
Deferred tax liabilities
399,800
178,300
125,800
85,076
-
Other long-term liabilities
-
100
-
-
-2
Total non-current liabilities
4,129,400
1,515,300
1,180,700
827,893
-
Total liabilities
5,066,700
2,551,200
2,217,800
1,395,733
-
Stockholders' equity
Common stock
18,400
18,400
18,400
18,436
-
Retained earnings
2,388,000
2,199,400
1,397,200
1,188,162
-
Total stockholders' equity
2,637,900
2,449,300
1,655,900
1,438,124
-
Total liabilities and stockholders' equity
7,739,900
5,065,400
3,951,100
2,856,733
-